Have a personal or library account? Click to login
The Role of Interferon-gamma Release Assay in Tuberculosis Control Cover

The Role of Interferon-gamma Release Assay in Tuberculosis Control

Open Access
|Mar 2012

References

  1. Broekmans JF, Migliori GB, Rieder HL, Lees J, Ruutu P, Loddenkemper R, Raviglione MC; World Health Organization, International Union Against Tuberculosis and Lung Disease, and Royal Netherlands Tuberculosis Association Working Group. European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Association (KNCV) Working Group. Eur Respir J 2002;19:765-75.10.1183/09031936.02.0026140211999007
  2. Jurčev-Savičević A, Katalinić-Janković V, Gjenero-Margan I, Šimunović A, Vidić Đ, Gunjača J, Obrovac M. Epidemiological patterns of tuberculosis in Croatia in the period 1996-2005. Coll Antropol 2011;35:523-8.
  3. Ministry of Health and Social Welfare of the Republic Of Croatia and Croatian National Institute of Public Health. Guidelines for tuberculosis control. Zagreb: Ministry of Health and Social Welfare of the Republic Of Croatia and National Institute of Public Health; 2010.
  4. Mack U, Migliori GB, Sester M, Rieder HL, Ehlers S, Goletti D, Bossink A, Magdorf K, Hölscher C, Kampmann B, Arend SM, Detjen A, Bothamley G, Zellweger JP, Milburn H, Diel R, Ravn P, Cobelens F, Cardona PJ, Kan B, Solovic I, Duarte R, Cirillo DM; C. Lange; TBNET. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J 2009;33:956-73.10.1183/09031936.0012090819407047
  5. Lange C, Mori T. Advances in the diagnosis of tuberculosis. Respirology 2010;15:220-40.10.1111/j.1440-1843.2009.01692.x20199641
  6. Harada N, Higuchi K, Yoshiyama T, Kawabe Y, Fujita A, Sasaki Y, Horiba M, Mitarai S, Yonemaru M, Ogata H, Ariga H, Kurashima A, Wada A, Takamori M, Yamagishi F, Suzuki K, Mori T, Ishikawa N. Comparison of the sensitivity and specificity of two whole blood interferon-gamma assays for M. tuberculosis infection. J Infect 2008;56:348-53.10.1016/j.jinf.2008.02.01118395264
  7. Cellestis [displayed 13 June 2011]. Available at http://www.cellestis.com/
  8. Lange C, Pai M, Drobniewski F, Migliori GB. Interferon-gamma release assays for the diagnosis of active tuberculosis: sensible or silly? Eur Respir J 2009;33:1250-3.10.1183/09031936.0001970919483044
  9. Lee SW, Oh DK, Lee SH, Kang HY, Lee CT, Yim JJ. Time interval to conversion of interferon-gamma release assay after exposure to tuberculosis. Eur Respir J 2011;37:1447-52.10.1183/09031936.0008951021148232
  10. Kobashi Y, Sugiu T, Mouri K, Obase Y, Miyashita N, Oka M. Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice. Eur Respir J 2009;33:812-5.10.1183/09031936.0007500819129287
  11. Lalvani A, Pareek M. Interferon gamma release assays: principles and practice. Enferm Infecc Microbiol Clin 2010;28:245-52.10.1016/j.eimc.2009.05.01219783328
  12. European Centre for Disease Prevention and Control. Use of interferon-gamma release assys in support of TB diagnosis. Stockholm: ECDC; 2011.
  13. Sester M, Sotgiu G, Lange C, Giehl C, Girardi E, Migliori GB, Bossink A, Dheda K, Diel R, Dominguez J, Lipman M, Nemeth J, Ravn P, Winkler S, Huitric E, Sandgren A, Manissero D. Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J 2011;37:100-11.10.1183/09031936.0011481020847080
  14. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008;149:177-84.10.7326/0003-4819-149-3-200808050-00241295198718593687
  15. Diel R, Loddenkemper R, Nienhaus A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis. Chest 2010;137:952-68.10.1378/chest.09-235020022968
  16. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007;146:340-54.10.7326/0003-4819-146-5-200703060-0000617339619
  17. Rieder HL. Epidemiologic Basis of Tuberculosis Control. Paris: IUATLD; 1999.
  18. Ewer K, Millington KA, Deeks JJ, Alvarez L, Bryant G, Lalvani A. Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am J Respir Crit Care Med 2006;174:831-9.10.1164/rccm.200511-1783OC16799072
  19. Connell TG, Ritz N, Paxton GA, Buttery JP, Curtis N, Ranganathan SC. A three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT.TB in children. PLoS One 2008;3:e2624.10.1371/journal.pone.0002624244054518612425
  20. Mori T. Usefulness of interferon-gamma release assays for diagnosing TB infection and problems with these assays. J Infect Chemother 2009;15:143-55.10.1007/s10156-009-0686-819554399
  21. Diel R, Loddenkemper R, Niemann S, Meywald-Walter K, Nienhaus A. Negative and positive predictive value of a whole-blood interferon-gamma release assay for developing active tuberculosis: an update. Am J Respir Crit Care Med 2011;183:88-95.10.1164/rccm.201006-0974OC20802162
  22. Higuchi K, Harada N, Mori T, Sekiya Y. Use of QuantiFERON-TB Gold to investigate tuberculosis contacts in a high school. Respirology 2007;12:88-92.10.1111/j.1440-1843.2006.01000.x17207031
  23. Dosanjh DP, Hinks TS, Innes JA, Deeks JJ, Pasvol G, Hackforth S, Varia H, Millington KA, Gunatheesan R, Guyot-Revol V, Lalvani A. Improved diagnostic evaluation of suspected tuberculosis. Ann Intern Med 2008;148:325-36.10.7326/0003-4819-148-5-200803040-00003276173418316751
  24. Goletti D, Stefania C, Butera O, Amicosante M, Ernst M, Sauzullo I, Vullo V, Cirillo D, Borroni E, Markova R, Drenska R, Dominguez J, Latorre I, Angeletti C, Navarra A, Petrosillo N, Lauria FN, Ippolito G, Migliori GB, Lange C, Girardi E. Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-Study. PLoS One 2008;3:e3417.10.1371/journal.pone.0003417256107318923709
  25. Madariaga MG, Jalali Z, Swindells S. Clinical utility of interferon gamma assay in the diagnosis of tuberculosis. J Am Board Fam Med 2007;20:540-7.10.3122/jabfm.2007.06.07010917954861
  26. Pai M, Kalantri S, Menzies D. Discordance between tuberculin skin test and interferon-gamma assays. Int J Tuberc Lung Dis 2006;10:942-3.
  27. Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K; IGRA Expert Committee; Centers for Disease Control and Prevention (CDC). Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep 2010;59(RR-5):1-25.
  28. Veerapathran A, Joshi R, Goswami K, Dogra S, Moodie EE, Reddy MV, Kalantri S, Schwartzman K, Behr MA, Menzies D, Pai M. T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data. PLoS One 2008;3:e1850.10.1371/journal.pone.0001850226699318365006
  29. Pai M, Joshi R, Dogra S, Mendiratta DK, Narang P, Kalantri S, Reingold AL, Colford JM Jr, Riley LW, Menzies D. Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med 2006;174:349-55.10.1164/rccm.200604-472OC264811616690977
  30. Pai M, O'Brien R. Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions? PLoS Med 2007;4:e208.10.1371/journal.pmed.0040208189132117564491
  31. Ringshausen FC, Nienhaus A, Torres Costa J, Knoop H, Schlösser S, Schultze-Werninghaus G, Rohde G. Within-subject variability of mycobacterium tuberculosis-specific gamma interferon responses in german health care workers. Clin Vaccine Immunol 2011;18:1176-82.10.1128/CVI.05058-11314731021593237
  32. Detjen AK, Loebenberg L, Grewal HM, Stanley K, Gutschmidt A, Kruger C, Du Plessis N, Kidd M, Beyers N, Walzl G, Hesseling AC. Short-term reproducibility of a commercial interferon gamma release assay. Clin Vaccine Immunol 2009;16:1170-5.10.1128/CVI.00168-09272554019535542
  33. Bergamini BM, Losi M, Vaienti F, D'Amico R, Meccugni B, Meacci M, De Giovanni D, Rumpianesi F, Fabbri LM, Balli F, Richeldi L. Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents. Pediatrics 2009;123:e419-24.10.1542/peds.2008-172219254978
  34. Pai M, Castro K, Mori T, Lienhardt C. Proceedings of the Second Global Symposium on Interferon-Gamma Release Assays. Session 9, Guidelines. Int J Tuberc Lung Dis 2010 June Suppl 1;14:S64-S69.
  35. Diel R, Loytved G, Nienhaus A, Castell S, Detjen A, Geerdes-Fenge H, Haas W, Hauer B, Königstein B, Maffei D, Magdorf K, Priwitzer M, Zellweger JP, Loddenkemper R. Neue Empfehlungen für die Umgebungsuntersuchungen bei Tuberkulose [New recommendations for contact tracing in tuberculosis, in German]. Pneumologie 2011;65:359-78.10.1055/s-0030-125643921560113
  36. Lighter J, Rigaud M, Eduardo R, Peng CH, Pollack H. Latent tuberculosis diagnosis in children by using the QuantiFERON-TB Gold In-Tube test. Pediatrics 2009;123:30-7.10.1542/peds.2007-361819117857
  37. Mandalakas AM, Detjen AK, Hesseling AC, Benedetti A, Menzies D. Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis 2011;15:1018-32.10.5588/ijtld.10.063121669030
  38. Bruzzese E, Bocchino M, Assante LR, Alessio M, Bellofiore B, Bruzzese D, Iorio R, Matarese A, Santoro G, Vajro P, Guarino A, Sanduzzi A. Gamma interferon release assays for diagnosis of tuberculosis infection in immunecompromised children in a country in which the prevalence of tuberculosis is low. J Clin Microbiol 2009;47:2355-7.10.1128/JCM.01320-08270848619420175
  39. Pavić I, Zrinski Topić R, Raos M, Aberle N, Dodig S. Interferon-γ release assay for the diagnosis of latent tuberculosis in children younger than 5 years of age. Pediatr Infect Dis J 2011;30:866-70.10.1097/INF.0b013e318220c52a21572371
  40. Piana F, Codecasa LR, Cavallerio P, Ferrarese M, Migliori GB, Barbarano L, Morra E, Cirillo DM. Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients. Eur Respir J 2006;28:31-4.10.1183/09031936.06.0011020516540502
  41. Kim EY, Lim JE, Jung JY, Son JY, Lee KJ, Yoon YW, Park BH, Moon JW, Park MS, Kim YS, Kim SK, Chang J, Kang YA. Perfomance of the tuberculin skin test and interferon-gamma release assay for detection of tuberculosis infection in immunocompromised patients in a BCG-vaccinated population. BMC Infect Dis 2009;9:207.10.1186/1471-2334-9-207280150820003535
  42. Dyrhol-Riise AM, Gran G, Wenzel-Larsen T, Blomberg B, Haanshuus CG, Mørkve O. Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country. BMC Infect Dis 2010;10:57.10.1186/1471-2334-10-57284227420210999
  43. Pai M, Joshi R, Bandyopadhyay M, Narang P, Dogra S, Taksande B, Kalantri S. Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis treatment. Infection 2007;35:98-103.10.1007/s15010-007-6114-z295198517401714
  44. Diel R, Loddenkemper R, Meywald-Walter K, Gottschalk R, Nienhaus A. Comparative performance of tuberculin skin test, QuantiFERON-TB-Gold In Tube assay, and T-Spot. TB test in contact investigations for tuberculosis. Chest 2009;135:1010-8.10.1378/chest.08-204819017873
  45. Pooran A, Booth H, Miller RF, Scott G, Badri M, Huggett JF, Rook G, Zumla A, Dheda K. Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis. BMC Pulm Med 2010;10:7.10.1186/1471-2466-10-7283763520170555
  46. Diel R, Nienhaus A, Loddenkemper R. Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany. Chest 2007;131:1424-34.10.1378/chest.06-272817494792
  47. Van Zyl-Smit RN, Zwerling A, Dheda K, Pai M. Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. PLoS One 2009;4:e8517.10.1371/journal.pone.0008517279519320041113
  48. Linas BP, Wong AY, Freedberg KA, Horsburgh Jr CR. Priorities for screening and treatment of latent tuberculosis infection in the United States. Am J Respir Crit Care Med 2011;184:590-601.10.1164/rccm.201101-0181OC317554621562129
  49. Choi JC, Shin JW, Kim JY, Park IW, Choi BW, Lee MK. The effect of previous tuberculin skin test on the follow-up examination of whole-blood interferon-gamma assay in the screening for latent tuberculosis infection. Chest 2008;133:1415-20.10.1378/chest.07-219318347207
  50. Perry S, Sanchez L, Yang S, Agarwal Z, Hurst P, Parsonnet J. Reproducibility of QuantiFERON-TB gold in-tube assay. Clin Vaccine Immunol 2008;15:425-32.10.1128/CVI.00398-07226827218199741
  51. Baker CA, Thomas W, Stauffer WM, Peterson PK, Tsukayama DT. Serial testing of refugees for latent tuberculosis using the QuantiFERON-gold in-tube: effects of an antecedent tuberculin skin test. Am J Trop Med Hyg 2009;80:628-33.10.4269/ajtmh.2009.80.628
  52. Igari H, Watanabe A, Sato T. Booster phenomenon of QuantiFERON-TB Gold after prior intradermal PPD injection. Int J Tuberc Lung Dis 2007;11:788-91.
  53. Naseer A, Naqvi S, Kampmann B. Evidence for boosting Mycobacterium tuberculosis-specific IFN-gamma responses at 6 weeks following tuberculin skin testing. Eur Respir J 2007;29:282-3.10.1183/09031936.0001780717540791
  54. Denkinger CM, Dheda K, Pai M. Guidelines on interferon-γ release assays for tuberculosis infection: concordance, discordance or confusion? Clin Microbiol Infect 2011;17:806-14.10.1111/j.1469-0691.2011.03555.x21682801
  55. Seidler A, Nienhaus A, Diel R. Review of epidemiological studies on the occupational risk of tuberculosis in low-incidence areas. Respiration 2005;72:431-46.10.1159/00008626116088290
  56. Diel R, Seidler A, Nienhaus A, Rusch-Gerdes S, Niemann S. Occupational risk of tuberculosis transmission in a low-incidence area. Respir Res 2005;6:35-45.10.1186/1465-9921-6-35108788415831092
  57. Centers for Disease Control and Prevention (CDC). Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings, 2005 [displayed 26. January 2012]. Available at http://www.cdc.gov/mmwr/pdf/rr/rr5417.pdf
  58. Pai M, Gokhale K, Joshi R, Dogra S, Kalantri S, Mendiratta DK, Narang P, Daley CL, Granich RM, Mazurek GH, Reingold AL, Riley LW, Colford JM Jr. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA 2005;293:2746-55.10.1001/jama.293.22.274615941804
  59. Nienhaus A, Schablon A, Bâcle CL, Siano B, Diel R. Evaluation of the interferon-gamma release assay in healthcare workers. Int Arch Occup Environ Health 2008;81:295-300.10.1007/s00420-007-0212-117605033
  60. Torres Costa J, Sá R, Cardoso MJ, Silva R, Ferreira J, Ribeiro C, Miranda M, Plácido JL, Nienhaus A. Tuberculosis screening in Portuguese healthcare workers using the tuberculin skin test and the interferon-gamma release assay. Eur Respir J 2009;34:1423-8.10.1183/09031936.0005380919948911
  61. Tripodi D, Brunet-Courtois B, Nael V, Audrain M, Chailleux E, Germaud P, Naudin F, Muller JY, Bourrut-Lacouture M, Durand-Perdriel MH, Gordeeff C, Guillaumin G, Houdebine M, Raffi F, Boutoille D, Biron C, Potel G, Roedlich C, Geraut C, Schablon A, Nienhaus A. Evaluation of the tuberculin skin test and the interferon-gamma release assay for TB screening in French healthcare workers. J Occup Med Toxicol 2009;4:30.10.1186/1745-6673-4-30279045119948042
  62. Zwerling A, van den Hof S, Scholten J, Cobelens F, Menzies D, Pai M. Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review. Thorax 2012;67:62-70.10.1136/thx.2010.14318021228420
  63. Torres Costa J, Silva R, Sá R, Cardoso MJ, Nienhaus A. Serial testing with the interferon-γ release assay in Portuguese healthcare workers. Int Arch Occup Environ Health 2011;84:461-9.10.1007/s00420-010-0571-x305854820721576
DOI: https://doi.org/10.2478/10004-1254-63-2012-2134 | Journal eISSN: 1848-6312 | Journal ISSN: 0004-1254
Language: English, Croatian, Slovenian
Page range: 49 - 59
Published on: Mar 26, 2012
Published by: Institute for Medical Research and Occupational Health
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2012 Anamarija Jurčev-Savičević, Vera Katalinić-Janković, Kornelija Miše, Ivan Gudelj, published by Institute for Medical Research and Occupational Health
This work is licensed under the Creative Commons License.

Volume 63 (2012): Issue 1 (March 2012)